← Back
$MBRX All transactions

Moleculin Biotech, Inc.

▲ BUY
9 / 10

Conviction

$ Value

$100K

Shares

270,270

Price

$0

Filed

Jun 23

Why this score? (9/10)
  • Open market buy (+3)
  • % of holdings >= 50% (+3)
  • C-suite insider (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Foster Jonathan P.

Title

Chief Financial Officer

CIK

0001545414

Roles

Officer

Transaction Details

Transaction Date

2025-06-23

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

287,587

Footnotes

Restricted stock units convert into common stock on a one-for-one basis. | Shares withheld for payment of taxes upon vesting of restricted stock unit awards. | On June 20, 2022, the reporting person was granted 10,846 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. | On June 22, 2023, the reporting person was granted 17,313 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. | On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval.

Filing Info

Accession No.

0001437749-25-021051

Form Type

4

Issuer CIK

0001659617

Foster Jonathan P.'s History

Date Ticker Type Value
2026-02-18 EMPD J $0
2026-02-18 EMPD J $0
2026-02-18 EMPD J $0
2025-11-12 MBRX A
2025-11-12 MBRX A
2025-11-04 MBRX M
2025-11-04 MBRX M $2K
2025-11-04 MBRX M $0
2025-07-21 VLCN A $200K
2025-07-17 VLCN A

Other Insiders at MBRX (90d)

No other insider activity at this issuer in the last 90 days.